Australian Clinical Labs Limited (ASX:ACL)
Share Pricing & News Healthcare

AUD 3.13

0.03 (0.968%)
(As on 2023-02-04 13:40:08 AEDT)
Previous Close Open Close*
3.1 3.11 3.13
Market Cap Dividend Yield (Annualized)
AUD 631.74M 16.50%

Day Range
3.1L 3.19 H
52 WEEK HIGH LOW
2.865L 5.88 H

Chart Price & Information

Last Trade 3.13
Change% 0.9677
52 W H/L 5.880/2.865
EBITDA 362.335M
NPAT After Abnormal Items 178.244M
Equity 232.557M
ROE% 79.86%
Total Liabilities 395.485M
Total Revenue 997.165M
Cash and Cash Equivalents 26.372M

Stock Information

Share price 3.13
Market Cap 631.74M
Price/Gross Cash Flow 3.11
Dividend Yield Excluding Special 11.55%
Ending Shares 201.834M
52-Week Range 5.880-2.865
Gross DPS (AUD) 0.7571
Gross Dividend Yield (Annualized) 16.50%
Earnings Yield 28.540
Net Tangible Asset (NTA) 0.33
P/E ratio 3.504
Sector P/E --
EPS 88.46
EV/EBITDA 3.06
Net Profit Margin (%) 18.76%
Gross Cash Flows Per Share 1.48
Net Gearing 101.48%
Sales Per Share 4.91
Book Value Per Share 1.15

Similar Companies

Related Articles

About Company

Australian Clinical Labs Limited (ACL) is a private provider of pathology services in Australia. ACL's mission is to combine talented people, medical and scientific leadership, with innovative thinking and technologies to empower decision making that saves and improves patients' lives. It is servicing over 90 private and public hospitals.

Dividends

Ex-Date Net Dividend Frank Flag Period End Date Type Payable

Event Calendar

Event Type Event Date Event Year
Report (Interim) 2023-02-23 2023
Report (Annual) 2022-09-23 2022
Report (Prelim) 2022-08-25 2022
Div Pay Date 2022-04-21 2022